drugset / Trial / NCT00272857
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
Phase 1
Completed
3 enrolled
Boston Children's Hospital
Children's Hospital Medical Center, Cincinnati · collabNational Heart, Lung, and Blood Institute (NHLBI) · collab
NaSingle-groupOpen-labelTreatment
Summary
Fanconi anemia (FA) is a disease that affects an individual's bone marrow. It is caused by a defective gene in the bone marrow cells that produce various types of blood cells. Individuals with FA may experience fatigue, bleeding, and increased infections. The purpose of this study is to evaluate the safety and effectiveness of a gene transfer procedure in generating new, healthy cells in individuals with FA.
Timeline
- Start
- 2004-08
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Retrovirus Construct | Unknown | — | — |